Chronic orofacial pain is a common clinical syndrome lacking specific and effective therapeutic agents due to the fact that the cellular mechanisms of chronic orofacial pain are poorly understood. Based on data from in vitro biochemical studies and non-orofacial, nerve injury-induced chronic pain models, we hypothesize that trigeminal nerve injury leads to altered expression of the calcium channel alpha-2-delta-1 subunit (Cava2d1) and thrombospondin-4 (TSP4) in trigeminal ganglia and associated brainstem and upper cervical spinal cord that plays a functional role in the development of neuropathic pain by promoting synaptogenesis. In this exploratory proposal, we plan to test if Cava2d1 and TSP4 induction by injury plays a causal role in the genesis and/or maintenance of neuropathic pain in an orofacial neuropathic pain model. We will perform Western blot analysis, immunohistochemical studies, and real-time PCR in trigeminal ganglia and associated brainstem/spinal cord samples from sham and infraorbital nerve injured animals to determine if there is a firm correlation between Cava2d1 and TSP4 expression and development of neuropathic pain. In addition, we will apply Cava2d1 and TSP4 antisense or mismatch oligonucleotides intrathecally to the nerve injury model, in a dose-dependent manner, before and after the onset of orofacial pain states to determine if preventing and reversing Cava2d1 and/or TSP induction by injury can block orofacial neuropathic pain development and maintenance, respectively. Completion of these studies will allow us to determine the functional contribution of injury-induced Cava2d1 and TSP expression to orofacial neuropathic pain and form the foundation for further investigation of the mechanisms underlying the contribution of these proteins in orofacial pain development. The final goal of the study is to identify new targets and pathways for the development of new medications for orofacial pain management. Project Narrative: Chronic orofacial pain derived from nerve injury, or orofacial neuropathic pain, is a common clinical syndrome lacking specific and effective therapeutic agents due to the fact that its cellular mechanisms are poorly understood. Existing data from in vitro biochemical studies and non-orofacial nerve injury pain models support that trigeminal nerve injury may lead to altered expression of the calcium channel alpha-2-delta-1 subunit (Cava2d1) and thrombospondin-4 (TSP4) in trigeminal ganglia and associated brainstem and upper cervical spinal cord that plays a functional role in orofacial pain development through a novel mechanism. In this exploratory proposal, we plan to test if trigeminal nerve injury causes altered expression of the Cava2d1 and TSP4 that contributes to the genesis and/or maintenance of neuropathic pain in an orofacial neuropathic pain model. We will test this hypothesis using biochemical and behavioral pharmacology approaches. Completion of this study will provide important information for the understanding of orofacial neuropathic pain mechanisms and the development of next generation of medications for orofacial neuropathic pain management.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21DE019298-02
Application #
7664604
Study Section
Special Emphasis Panel (ZDE1-JH (30))
Program Officer
Kusiak, John W
Project Start
2008-08-01
Project End
2011-07-31
Budget Start
2009-08-01
Budget End
2011-07-31
Support Year
2
Fiscal Year
2009
Total Cost
$228,750
Indirect Cost
Name
University of California Irvine
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
046705849
City
Irvine
State
CA
Country
United States
Zip Code
92697
Kim, Chang Soo; Ingato, Dominique; Wilder-Smith, Petra et al. (2018) Stimuli-disassembling gold nanoclusters for diagnosis of early stage oral cancer by optical coherence tomography. Nano Converg 5:3
Li, Kang-Wu; Yu, Yanhui Peter; Zhou, Chunyi et al. (2014) Calcium channel ?2?1 proteins mediate trigeminal neuropathic pain states associated with aberrant excitatory synaptogenesis. J Biol Chem 289:7025-37
Zhou, C; Luo, Z D (2014) Electrophysiological characterization of spinal neuron sensitization by elevated calcium channel alpha-2-delta-1 subunit protein. Eur J Pain 18:649-58
Li, K-W; Kim, D-S; Zaucke, F et al. (2014) Trigeminal nerve injury-induced thrombospondin-4 up-regulation contributes to orofacial neuropathic pain states in a rat model. Eur J Pain 18:489-95
Zeng, J; Kim, D; Li, K-W et al. (2013) Thrombospondin-4 contributes to spinal cord injury-induced changes in nociception. Eur J Pain 17:1458-64
Luo, Z David (2012) Advancements in pain research. Methods Mol Biol 851:1-8
Shim, Min Suk; Kwon, Young Jik (2010) Acid-transforming polypeptide micelles for targeted nonviral gene delivery. Biomaterials 31:3404-13
Shim, Min Suk; Kim, Chang Soo; Ahn, Yeh-Chan et al. (2010) Combined multimodal optical imaging and targeted gene silencing using stimuli-transforming nanotheragnostics. J Am Chem Soc 132:8316-24
Shim, Min Suk; Wang, Xi; Ragan, Regina et al. (2010) Dynamics of nucleic acid/cationic polymer complexation and disassembly under biologically simulated conditions using in situ atomic force microscopy. Microsc Res Tech 73:845-56
Park, John; Luo, Z David (2010) Calcium channel functions in pain processing. Channels (Austin) 4:510-7

Showing the most recent 10 out of 12 publications